Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Vitti, MD
Regeneron Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
188 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Calgary, Alberta, Canada
- Facility name not stated
Vancouver, British Columbia, Canada
- Facility name not stated
Victoria, British Columbia, Canada
- Facility name not stated
Halifax, Nova Scotia, Canada
- Facility name not stated
London, Ontario, Canada
- Facility name not stated
Mississauga, Ontario, Canada
- Facility name not stated
Ottawa, Ontario, Canada
- Facility name not stated
Toronto, Ontario, Canada
- Facility name not stated
Toronto, Ontario, Canada
- Facility name not stated
Montreal, Quebec, Canada
- Facility name not stated
Montreal, Quebec, Canada
- Facility name not stated
Regina, Saskatchewan, Canada
- Facility name not stated
Birmingham, Alabama, United States
- Facility name not stated
Birmingham, Alabama, United States
- Facility name not stated
Phoenix, Arizona, United States
- Facility name not stated
Phoenix, Arizona, United States
- Facility name not stated
Tucson, Arizona, United States
- Facility name not stated
Tucson, Arizona, United States
- Facility name not stated
Beverly Hills, California, United States
- Facility name not stated
Campbell, California, United States
- Facility name not stated
Fullerton, California, United States
- Facility name not stated
Glendale, California, United States
- Facility name not stated
Irvine, California, United States
- Facility name not stated
La Jolla, California, United States
- Facility name not stated
Loma Linda, California, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Menlo Park, California, United States
- Facility name not stated
Mountain View, California, United States
- Facility name not stated
Oakland, California, United States
- Facility name not stated
Palm Springs, California, United States
- Facility name not stated
Pasadena, California, United States
- Facility name not stated
Poway, California, United States
- Facility name not stated
Sacramento, California, United States
- Facility name not stated
San Diego, California, United States
- Facility name not stated
San Francisco, California, United States
- Facility name not stated
Santa Ana, California, United States
- Facility name not stated
Torrance, California, United States
- Facility name not stated
Ventura, California, United States
- Facility name not stated
Westlake Village, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2007
- Primary completion
- 30 Sept 2010
- Completion
- 31 Jul 2011
- Last update posted
- 28 Dec 2012
- Registered enrollment
- 1,217
- Registry id
- NCT00509795
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.